Racura Oncology
(ASX) RAC
Racura Oncology Financials at a Glance
Market Cap
$501.16M
Revenue (TTM)
$6.88M
Net Income (TTM)
$17.04M
EPS (TTM)
$-0.05
P/E Ratio
-51.21
Dividend
$0.00
Beta (Volatility)
0.06 (Low)
Dividend
$0.00
Beta (Volatility)
0.06 (Low)
Price
$2.75
Volume
172,312
Open
$2.79
Price
$2.75
Volume
172,312
Open
$2.79
Previous Close
$2.75
Daily Range
$2.71 - $2.79
52-Week Range
$0.92 - $4.90
Dividend
$0.00
Beta (Volatility)
0.06 (Low)
Price
$2.75
Volume
172,312
Open
$2.79
Previous Close
$2.75
Daily Range
$2.71 - $2.79
52-Week Range
$0.92 - $4.90
RAC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Racura Oncology
Industry
Biotechnology
Sector
Health CareCEO
Daniel Tillett, PhD
Website
www.raceoncology.comHeadquarters
Sydney, NSW 2000, AU
RAC Financials
Key Financial Metrics (TTM)
Gross Margin
50%
Operating Margin
-13%
Net Income Margin
-12%
Return on Equity
-42%
Return on Capital
-43%
Return on Assets
-38%
Earnings Yield
-1.95%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$501.16M
Shares Outstanding
182.24M
Volume
172.31K
Short Interest
0.00%
Avg. Volume
192.87K
Financials (TTM)
Gross Profit
$5.41M
Operating Income
$3.77M
EBITDA
$4.43M
Operating Cash Flow
$4.57M
Capital Expenditure
$3.00
Free Cash Flow
$4.57M
Cash & ST Invst.
$13.67M
Total Debt
$0.00
Racura Oncology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$140.60K
+0.0%
Gross Margin
0.00%
N/A
Market Cap
$501.16M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$4.10M
+27.6%
EBITDA
$5.52M
+42.1%
Quarterly Fundamentals
Net Cash
$20.94M
+52.7%
Accounts Receivable
$32.30K
-99.2%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-37.91%
N/A
Return on Invested Capital
-43.24%
N/A
Free Cash Flow
$2.19M
+73.2%
Operating Cash Flow
$2.19M
+73.2%